News
INBS
2.660
-2.92%
-0.080
Weekly Report: what happened at INBS last week (0415-0419)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. Kineta stock moved upwards by 16.62% and Erasca stock rose 13.73%. Nexalin Technology (NASDAQ:NXL) stock fell 18.4% during the day.
Benzinga · 4d ago
Intelligent Bio Solutions reports Preliminary Unaudited Fiscal Q3 results
Seeking Alpha · 4d ago
Intelligent Bio Solutions expects approximate unaudited Q3 revenue of $0.82M
Seeking Alpha · 5d ago
*Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS
Dow Jones · 5d ago
INTELLIGENT BIO - CARTRIDGE AND READER SALES ARE EXPECTED TO INCREASE 25% AND 63%, RESPECTIVELY, FROM JULY 1, 2023, THROUGH TO MARCH 31, 2024
Reuters · 5d ago
INTELLIGENT BIO SOLUTIONS INC - SEES QTRLY YEAR-OVER-YEAR INCREASE OF 17% IN CARTRIDGE SALES
Reuters · 5d ago
INTELLIGENT BIO SOLUTIONS INC. ANNOUNCES PRELIMINARY UNAUDITED FISCAL THIRD QUARTER AND NINE-MONTH REVENUE RESULTS
Reuters · 5d ago
Weekly Report: what happened at INBS last week (0408-0412)?
Weekly Report · 04/15 11:08
INTELLIGENT BIO SOLUTIONS: FOR UNIT, GRANT OF EUROPEAN PATENT WITH UNITARY EFFECT FOR DSR-PLUS CARTRIDGE READER
Reuters · 04/11 12:33
Weekly Report: what happened at INBS last week (0401-0405)?
Weekly Report · 04/08 11:13
Looking Into Intelligent Bio Solutions's Recent Short Interest
Intelligent Bio Solutions's short percent of float has risen 57.64% since its last report. The company has 90 thousand shares sold short, which is 3.2% of its float. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 04/05 16:45
Weekly Report: what happened at INBS last week (0325-0329)?
Weekly Report · 04/01 11:11
Weekly Report: what happened at INBS last week (0318-0322)?
Weekly Report · 03/25 11:14
Intelligent Bio Solutions Inc Files For Offering Of Up To 6.8M Shares By The Selling Stockholders
Benzinga · 03/18 19:36
Weekly Report: what happened at INBS last week (0311-0315)?
Weekly Report · 03/18 11:12
Intelligent Bio Solutions Inc: Current report
Press release · 03/13 10:11
*Intelligent Bio Solutions Closes $10.1M Private Placement Priced At-the-Market >INBS
Dow Jones · 03/12 23:38
Intelligent Bio Solutions Announces $10.1 Mln Private Placement
NASDAQ · 03/11 13:43
Press Release: Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Intelligent Bio Solutions Inc. Announces $10.1 million Private Placement Priced At-the-Market Under Nasdaq Rules. The Company is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The company's Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis.
Dow Jones · 03/11 12:30
More
Webull provides a variety of real-time INBS stock news. You can receive the latest news about Intelligent Bio Solutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About INBS
Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.